Historical salary details - Dr. Brian L. Kotzin, M.D., Independent Director, Argen X SE - ADR
Dr. Brian L. Kotzin, M.D. is the Independent Director of Argen X SE - ADR. They also hold 2 other positions in Rigel Pharmaceuticals and Kyverna Therapeutics Inc..
Dr. Brian L. Kotzin, M.D.
Independent Director
$ 1.2 M
Gross Remuneration
-
Current Company
Argen X SE - ADR
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Argen X SE - ADR | Independent Director | 765.7 K | - |
| 2024 | Rigel Pharmaceuticals | Independent Director | 367.7 K | 165.3 % |
| 2024 | Kyverna Therapeutics Inc. | Independent Director | 49.7 K | -80.5 % |
| 2023 | Kyverna Therapeutics Inc. | Independent Director | 255.1 K | - |
| 2023 | Biora Therapeutics Inc | Independent Director | 185.1 K | -14.3 % |
| 2023 | Rigel Pharmaceuticals | - | 138.6 K | -16.6 % |
| 2022 | Biora Therapeutics Inc | Independent Director | 215.9 K | -11.0 % |
| 2022 | Rigel Pharmaceuticals | Independent Director | 166.2 K | -30.3 % |
| 2021 | Biora Therapeutics Inc | Independent Director | 242.7 K | 26.0 % |
| 2021 | Rigel Pharmaceuticals | Independent Director | 238.4 K | 73.1 % |
| 2020 | Biora Therapeutics Inc | Independent Director | 192.6 K | -33.7 % |
| 2020 | Rigel Pharmaceuticals | Independent Director | 137.7 K | -14.2 % |
| 2019 | Biora Therapeutics Inc | Independent Director | 290.4 K | - |
| 2019 | Rigel Pharmaceuticals | Independent Director | 160.5 K | -3.4 % |
| 2018 | Rigel Pharmaceuticals | Independent Director | 166.2 K | 12.7 % |
| 2017 | Rigel Pharmaceuticals | Independent Director | 147.5 K | - |